Search results
Replay wins IND clearance for PRAME T cell cancer therapy
Clinical Trials Arena via Yahoo Finance· 19 hours agoGenome writing company Replay Bio has had its investigational new drug (IND) application cleared by...
New technique improves T cell-based immunotherapies for solid tumors
Medical Xpress· 15 hours agoScientists from Scripps Research have enhanced an existing immunotherapy by removing the sugar coating surrounding solid tumors—such as in melanoma, breast, and prostate cancer—so T cells can ...
Revolutionizing Cancer Treatment: Key to Prolonging CAR T Cell Life Uncovered
SciTechDaily· 2 days agoFOXO1 is required for T cell memory and is linked to longer-lasting clinical outcomes in CAR T cell ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 hours agoPlanegg/Martinsried, May 2, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of
Biomarkers identified for successful treatment of bone marrow tumors
Medical Xpress· 6 days agoCAR T cell therapy has proven effective in treating various hematological cancers. In a clinical study, researchers from the University ...
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop...
WFRV 5 Green Bay· 9 hours agoPoseida is advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases.
Do cutting-edge CAR-T-cell therapies cause cancer? What the data say
Nature· 2 days agoRegulators have identified around 30 cases of cancer linked to this blockbuster treatment. But is...
Keto supplement may improve immunotherapy for prostate cancer
Futurity· 2 days agoAdding a pre-ketone supplement, a component of a high-fat, low-carb ketogenic diet, to a type of...
CD70 Antibodies CD70 Targeting Therapies Clinical Trials Market Opportunity Insight
Benzinga· 23 hours agoDelhi, May 01, 2024 (GLOBE NEWSWIRE) -- Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024 Report Highlights: CD70 Targeting Therapies In Clinical Trials: > 20 TherapiesCD 70
Astellas and Poseida join forces for cancer cell therapy By Investing.com
Investing.com· 8 hours agoAstellas Pharma Inc. (TSE: 4503) and Poseida Therapeutics, Inc. (NASDAQ: PSTX) have entered a...